Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. (2018)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2017-315144
PubMed Identifier: 29080858
Publication URI: http://europepmc.org/abstract/MED/29080858
Type: Journal Article/Review
Volume: 67
Parent Publication: Gut
Issue: 12
ISSN: 0017-5749